Glass Label/Claim Audit

Euphoria

Durable audit route for one claim-like target. This page shows source-use records, assessment rationale, active challenges, revisions, and graph edges tied to the same target identity.

evidence high
Assessment Rationale

euphoria is included with provisional confidence because the record has direct section evidence but still needs endpoint-specific interpretation before it should be read as a strong clinical claim.

The assessment is anchored to the cited effect record rather than inferred from the compound name alone.

Evidence Reviewed

Sources considered for this assessment[1][2]

Claim Scope
Endpoint
Euphoria
Context
Effect
Does not mean
  • - Not proof that every user will experience this effect
  • - Not a complete effect-size claim
  • - Not individualized medical guidance
Basis For Judgment
01Record supportMedium

The row has an explicit structured record and citation mapping.

02Endpoint directnessLow

The current seed evidence does not yet carry the same detailed endpoint interpretation as Taurine.

03CMS readinessMedium

The audit path is present; additional source interpretation can be added without changing the schema.

Raises confidence
  • - structured record exists
  • - citation support is mapped to this row
Limits confidence
  • - interpretation remains provisional
  • - effect size and population scope need fuller review
Disputable assumptions
  • - endpoint inference
  • - population generalization
  • - whether the row should be strengthened or narrowed
Source Use Records

Local evidence attached to this claim

MixedDirect Endpoint EvidenceDirect Nonhuman Endpoint5/5 quality fields

Pharmacology and clinical effects of diacetylmorphine and morphine

Euphoria is represented as a sought psychoactive effect in nonmedical contexts and a reinforcement signal relevant to misuse liability.

This source is used to support the Euphoria effect row in this compound monograph.

Endpoint
Euphoria
Population
Adults in clinical or toxicology contexts
Dose / Exposure
Not directly applicable
Duration
Not directly applicable
Directness
Direct Nonhuman Endpoint
MixedDirect Endpoint EvidenceDirect Nonhuman Endpoint5/5 quality fields

Drug harms in the UK: a multicriteria decision analysis

Euphoria is represented as a sought psychoactive effect in nonmedical contexts and a reinforcement signal relevant to misuse liability.

This source is used to support the Euphoria effect row in this compound monograph.

Endpoint
Euphoria
Population
Adults in clinical or toxicology contexts
Dose / Exposure
Not directly applicable
Duration
Not directly applicable
Directness
Direct Nonhuman Endpoint